Vanda Pharmaceuticals Inc (NASDAQ:VNDA) shares, rose in value on Friday, March 28, with the stock price up by 1.96% to the previous day’s close as strong demand from buyers drove the stock to $4.69.
Actively observing the price movement in the last trading, the stock closed the session at $4.60, falling within a range of $4.57 and $4.705. The value of beta (5-year monthly) was 0.69. Referring to stock’s 52-week performance, its high was $6.75, and the low was $3.87. On the whole, VNDA has fluctuated by -0.21% over the past month.
With the market capitalization of Vanda Pharmaceuticals Inc currently standing at about $273.50 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-12.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 222.86M, with a low estimate of 41.4M and a high estimate of 49M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 45.13M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that VNDA’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of VNDA currently trading nearly -3.65% and 0.57% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 46.18, while the 7-day volatility ratio is showing 3.08% which for the 30-day chart, stands at 4.29%. Furthermore, Vanda Pharmaceuticals Inc (VNDA)’s beta value is 0.73, and its average true range (ATR) is 0.20.
A comparison of Vanda Pharmaceuticals Inc (VNDA) with its peers suggests the former has fared considerably weaker in the market. VNDA showed an intraday change of 1.96% in last session, and over the past year, it grew by 21.50%%.
Data on historical trading for Vanda Pharmaceuticals Inc (NASDAQ:VNDA) indicates that the trading volumes over the past 10 days have averaged 0.52 and over the past 3 months, they’ve averaged 630.22K. According to company’s latest data on outstanding shares, there are 58.31 million shares outstanding.
Nearly 6.73% of Vanda Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 75.10% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.56 million shares as on 2025-03-14, resulting in a short ratio of 4.57. According to the data, the short interest in Vanda Pharmaceuticals Inc (VNDA) stood at 738.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 3.72 million. The stock has fallen by -2.09% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the VNDA stock heading into the next quarter.
